NCT00236652View on ClinicalTrials.gov

A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

June 30, 2005

Conditions
Maxillary Sinusitis
Interventions
DRUG

levofloxacin

All Listed Sponsors
collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236652 - A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days. | Biotech Hunter | Biotech Hunter